Correlation Between Quantum Genomics and Neovacs SA
Can any of the company-specific risk be diversified away by investing in both Quantum Genomics and Neovacs SA at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Quantum Genomics and Neovacs SA into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Quantum Genomics SA and Neovacs SA, you can compare the effects of market volatilities on Quantum Genomics and Neovacs SA and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Quantum Genomics with a short position of Neovacs SA. Check out your portfolio center. Please also check ongoing floating volatility patterns of Quantum Genomics and Neovacs SA.
Diversification Opportunities for Quantum Genomics and Neovacs SA
0.0 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Quantum and Neovacs is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Quantum Genomics SA and Neovacs SA in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Neovacs SA and Quantum Genomics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Quantum Genomics SA are associated (or correlated) with Neovacs SA. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Neovacs SA has no effect on the direction of Quantum Genomics i.e., Quantum Genomics and Neovacs SA go up and down completely randomly.
Pair Corralation between Quantum Genomics and Neovacs SA
If you would invest 7.21 in Quantum Genomics SA on December 2, 2024 and sell it today you would earn a total of 0.00 from holding Quantum Genomics SA or generate 0.0% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Flat |
Strength | Insignificant |
Accuracy | 100.0% |
Values | Daily Returns |
Quantum Genomics SA vs. Neovacs SA
Performance |
Timeline |
Quantum Genomics |
Neovacs SA |
Quantum Genomics and Neovacs SA Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Quantum Genomics and Neovacs SA
The main advantage of trading using opposite Quantum Genomics and Neovacs SA positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Quantum Genomics position performs unexpectedly, Neovacs SA can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Neovacs SA will offset losses from the drop in Neovacs SA's long position.Quantum Genomics vs. Poxel SA | Quantum Genomics vs. Biophytis SA | Quantum Genomics vs. Gensight Biologics SA | Quantum Genomics vs. OSE Pharma SA |
Neovacs SA vs. Europlasma SA | Neovacs SA vs. Biophytis SA | Neovacs SA vs. Cellectis | Neovacs SA vs. Innate Pharma |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Insider Screener module to find insiders across different sectors to evaluate their impact on performance.
Other Complementary Tools
Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
Technical Analysis Check basic technical indicators and analysis based on most latest market data |